Frederick National Laboratory for Cancer Research

06/15/2026

Experts from across the scientific community will gather at Hood College this week for the fourth Life Sciences Symposium to discuss practical solutions to the “reproducibility crisis” in research.

“The hope is that we can brainstorm and actually try to influence these specific areas with workable, constructive solutions,” said Leonard Freedman, Ph.D., Frederick National Laboratory chief science officer.

To view the event agenda, visit: https://heyor.ca/0xGVyK

06/11/2026

Xiaoyu Wang of the Frederick National Laboratory for Cancer Research contributed to a 20-institution study that developed genetic risk assessment tools to improve breast cancer risk prediction for women of African ancestry.

Published in Nature Portfolio Genetics, the study introduces polygenic risk score models with the highest reported predictive performance to date for this population, a step toward more accurate risk assessment and more informed screening decisions: https://heyor.ca/pEeVmn

Image

06/08/2026

Discover how a groundbreaking collaboration bringing together the L...

06/03/2026

An FDA-approved chikungunya vaccine manufactured by the Frederick National Laboratory for Cancer Research and tested in early clinical trials a decade ago may become a bigger player in global health following a series of adverse event reports linked to the only other available vaccine for the mosquito-borne disease 👉 https://heyor.ca/uBCdby

Image

06/02/2026

A major step forward for gene therapy research 👉 https://heyor.ca/wnX5Uc

Frederick National Laboratory for Cancer Research, in collaboration with NIH’s National Center for Advancing Translational Sciences (NCATS), has launched the Gene Therapy Immunology and Standards Laboratory & Initiative – a national resource designed to support the scientific community.

This effort aims to standardize how gene therapies are studied and reported, helping accelerate progress in this rapidly evolving field that targets diseases at their genetic roots.

Frederick National Laboratory for Cancer Research and the National Center for Advancing Translational Sciences Therapeutic Development Branch in the National Institutes of Health have launched the Gene Therapy Immunology and Standards Laboratory and Initiative, a national resource to aid the scienti...

05/26/2026

This event is a great opportunity for companies, investors, entrepreneurs and technology scouts seeking technologies to commercialize. Save the date and register today: https://heyor.ca/t7yN4g

National Cancer Institute

05/20/2026

Each year, the Frederick National Laboratory for Cancer Research proudly supports Relay For Life of Frederick County, MD. Last Friday, 26 employees came together to participate in this meaningful community event.

Throughout the evening, employees stayed engaged in a variety of activities. Volunteers assembled chemo care bags for patients at the James M. Stockman Cancer Institute at Frederick Health, walked laps in honor of cancer survivors and in memory of those lost to the disease, enjoyed carnival games hosted by fellow teams, and shared picnic-style food provided by colleagues.

05/14/2026

Looking for something fun to do tomorrow? We're joining Relay For Life of Frederick County, MD on May 15 to raise money for and to celebrate our local survivors. Join for a night filled with family-friendly activities. Be sure to stop by our booth to say hi.

05/05/2026

Learn how to conduct clinical trials during infectious disease outbreaks, build research infrastructure in resource-limited areas, and improve patient outcomes. Our Global Clinical Research Educational Modules are here to help you advance your skills 👉 https://heyor.ca/QMvaTI

The Frederick National Laboratory Global Clinical Research Educational Modules (FNL GCREM) curriculum is a series of modules developed by our Clinical Monitoring Research Program in partnership with the National Institute of Allergy and Infectious Diseases Division of Clinical Research to share our....

04/29/2026

Have you read the latest ? Guest writers Dr. Philipp Hafner and Dr. Dietrich Ruess discuss how RAS pathway inhibition appears to ignite a metabolic “fire” within the tumor cell 👉

The RAS Dialogue Blog posts are written by RAS experts sharing the latest research, updates, and scientific RAS news. The content is curated by the RAS Initiative.